Med-Tech Innovation July 25, 2024
Oliver Johnson

Cresset, a provider of integrated in silicosolutions for drug discovery has announced the release of V9 – the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark, the company’s bioisostere replacement solution.

Flare users will be able to use the range of capabilities brought by this integration to generate ideas for their design projects, while enabling improved efficiencies with custom workflows and task automation via the Flare Python API.

Key Spark features including scaffold hopping and R-group replacement, ligand macrocyclisation, growing and docking, joining two ligands, water replacement and access to the new ‘Linkers’ databases, for linker degrader design, allow even more creativity and streamlining of the small molecule discovery process.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
Promise and Perils of AI in Medicine
Samsung Acquires AI-Powered Prenatal Ultrasound Startup
Abbott launches its first over-the-counter continuous glucose monitor in the U.S.
Ounce of Prevention: Are All Locations Where You Dispense DMEPOS Individually Enrolled in Medicare?
Samsung finalizes $92M acquisition of French ultrasound AI firm Sonio

Share This Article